Rumeenia -
rumeenia -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
zeliftan 6 mg/0,4 mg
adamed pharma s.a. - polonia - combinatii (solifenacinum succinat+tamsulosinum) - compr. cu elib. modif. - 6mg/0,4mg - medicamente pt.tratamentul hipertrofiei benigne de prostata antagonisti ai receptorilor alfa-adrenergici
Rumeenia -
rumeenia -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
mingerlan 6 mg/0,4 mg
synthon hispania s.l. - spania - combinatii (solifenacinum succinat+tamsulosinum) - compr. cu elib. modif. - 6mg/0,4mg - medicamente pt.tratamentul hipertrofiei benigne de prostata antagonisti ai receptorilor alfa-adrenergici
Rumeenia -
rumeenia -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
orungal 100 mg
janssen-cilag spa - italia - itraconazolum - caps. - 100mg - antimicotice de uz sistemic derivati de triazol
Euroopa Liit -
rumeenia -
EMA (European Medicines Agency)
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenți antineoplazici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
Moldova -
rumeenia -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
digoxin grindeks 0,25 mg comprimate
grindeks sa - digoxinum - comprimate - 0,25 mg
Euroopa Liit -
rumeenia -
EMA (European Medicines Agency)
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale pentru uz sistemic - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
Euroopa Liit -
rumeenia -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
Euroopa Liit -
rumeenia -
EMA (European Medicines Agency)
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenți antineoplazici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
Moldova -
rumeenia -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
digoxin grindeks 0.25 mg comprimate
grindeks sa - digoxinum - comprimate - 0.25 mg